Overview

Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps

Status:
RECRUITING
Trial end date:
2028-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the feasibility of extending the dosing intervals of biological therapies while maintaining optimal treatment effects in chronic rhinosinusitis with nasal polyps (CRSwNP).
Phase:
PHASE4
Details
Lead Sponsor:
Rigshospitalet, Denmark